Fidelity Contrafund is an online platform offering mutual fund research tools.
Fidelity Contrafund - Fidelity Advisor New Insights Fund is an open ended equity mutual fund launched by Fidelity Investments. It is co-managed by Fidelity Management & Research Company, FMR Co., Inc., Fidelity Research & Analysis Company, Fidelity Management & Research (U.K.) Inc., Fidelity International Investment Advisors (U.K.) Limited, Fidelity Investments Japan Limited, and Fidelity International Investment Advisors. The fund primarily invests in the public equity markets across the globe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the growth or value stocks of companies. It employs fundamental analysis with a bottom-up approach with a focus on factors such as financial condition, earnings outlook, strategy, management, industry position, and economic and market conditions to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Index. Fidelity Contrafund - Fidelity Advisor New Insights Fund was formed on August 12, 2003 and is domiciled in the United States.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 22, 2018
Heal
|
Series C | $20M | Apps | — |
Nov 19, 2009
Standard BioTools
|
Series Unknown | $7.50M | Biotechnology | — |
Fidelity Contrafund has had 1 exits. Fidelity Contrafund most notable exits include Standard BioTools
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Feb 10, 2011 | Standard BioTools | IPO | Biotechnology | Detail |